Technical Analysis for HTBX - Heat Biologics, Inc.

Grade Last Price % Change Price Change
grade F 1.24 -3.88% -0.05
HTBX closed down 3.88 percent on Friday, March 22, 2019, on 29 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical HTBX trend table...

Date Alert Name Type % Chg
Mar 22 Wide Bands Range Expansion 0.00%
Mar 21 Wide Bands Range Expansion -3.88%
Mar 20 Narrow Range Bar Range Contraction -0.80%
Mar 20 Wide Bands Range Expansion -0.80%
Mar 20 Oversold Stochastic Weakness -0.80%
Mar 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.36%
Mar 19 Wide Bands Range Expansion -2.36%
Mar 19 Oversold Stochastic Weakness -2.36%
Mar 18 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.62%
Mar 18 Stochastic Buy Signal Bullish -4.62%

Older signals for HTBX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Heat Biologics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of various cellular therapeutic vaccines for a range of cancers and infectious diseases. It is developing Immune Pan Antigen Cytotoxic therapy, a platform technology that delivers human cells that are reprogrammed to pump out various cancer associated antigens together with a potent immune adjuvant. The company's products under development include HS-110 that is in Phase II clinical trials for the treatment of non-small cell lung cancer; HS-410 for the bladder cancer treatment; HS-310 to treat ovarian cancer; and HS-510 for treating triple negative breast cancer. Its products also comprise HS-HIV product candidate for the treatment and prevention of HIV. The company was founded in 2008 and is based in Chapel Hill, North Carolina.
Biotechnology Biopharmaceutical Cancer Life Sciences Infectious Diseases Treatment Of Cancer Cancers Non Small Cell Lung Cancer Ovarian Cancer Vaccination HIV Cancer Treatment Platform Technology Vaccine Cancer Vaccine Treatment Of Non Small Cell Lung Cancer Biotechnology Companies Bladder Cancer Triple Negative Breast Cancer Chapel Hill Heat Biologics Neuvenge
Is HTBX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.3
52 Week Low 0.95
Average Volume 728,721
200-Day Moving Average 1.706
50-Day Moving Average 1.3648
20-Day Moving Average 1.328
10-Day Moving Average 1.251
Average True Range 0.0957
ADX 13.96
+DI 22.3375
-DI 22.1211
Chandelier Exit (Long, 3 ATRs ) 1.5129
Chandelier Exit (Short, 3 ATRs ) 1.4471
Upper Bollinger Band 1.6322
Lower Bollinger Band 1.0238
Percent B (%b) 0.36
BandWidth 45.813253
MACD Line -0.0368
MACD Signal Line -0.0336
MACD Histogram -0.0032
Fundamentals Value
Market Cap 44.37 Million
Num Shares 35.8 Million
EPS -0.43
Price-to-Earnings (P/E) Ratio -2.88
Price-to-Sales 26.16
Price-to-Book 2.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.35
Resistance 3 (R3) 1.36 1.33 1.34
Resistance 2 (R2) 1.33 1.31 1.33 1.33
Resistance 1 (R1) 1.29 1.29 1.27 1.28 1.32
Pivot Point 1.26 1.26 1.25 1.25 1.26
Support 1 (S1) 1.21 1.23 1.20 1.20 1.16
Support 2 (S2) 1.18 1.21 1.18 1.15
Support 3 (S3) 1.14 1.18 1.15
Support 4 (S4) 1.13